Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Pacific Biosciences of California (PACB)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pacific Biosciences's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
5.20 +0.73    +16.33%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
5.09
-0.11
-2.12%
19:49:42 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US69404D1081 
CUSIP:  69404D108
  • Volume: 5,908,436
  • Bid/Ask: 5.06 / 5.15
  • Day's Range: 4.27 - 5.24
Pacific Biosciences 5.20 +0.73 +16.33%

Pacific Biosciences of California Company Profile

 
Get an in-depth profile of Pacific Biosciences of California, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryLife Sciences Tools & Services
SectorHealthcare
Employees

728

Equity Type

ORD

Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed its Single Molecule, Real-Time (SMRT) technology, which enables single molecule, real-time detection of nucleic acid sequences, to address many of the limitations of previous sequencing technologies. The Company’s products include Sequel, Sequel II and Sequel IIe instruments and SMRT Cell 8M, which together can sequence up to approximately eight million deoxyribonucleic acid (DNA) molecules simultaneously, and the previous generation Sequel instrument and Sequel SMRT Cell 1M, which together conduct, monitor, and analyze single molecule biochemical reactions in real time. The Company's Sequel IIe System increases computational capacity and is designed to enable customers to generate PacBio HiFi reads.

Contact Information

Address 1305 O’Brien Drive
Menlo Park, 94025
United States
Phone 650 521 8000
Fax -
Web www.pacb.com

Top Executives

Name Age Since Title
William W. Ericson 62 2004 Independent Director
Hannah A. Valantine 69 2021 Independent Director
John F. Milligan 60 2013 Independent Chairman
Christian O. Henry 53 2018 President, CEO & Director
Joseph V. Bonventre 71 - Member of the Scientific Advisory Board
Lucy Shapiro 80 2012 Independent Director
Harold Craighead - - Member of the Scientific Advisory Board
Kenneth A. Johnson - - Member of the Scientific Advisory Board
Watt W. Webb - - Member of the Scientific Advisory Board
Elaine R. Mardis 58 2008 Member of the Scientific Advisory Board
Chenming C. Hu 73 - Member of the Scientific Advisory Board
Roger D. Kornberg 74 - Member of the Scientific Advisory Board
Harry B. Gray - - Member of the Scientific Advisory Board
Marshall L. Mohr 65 2012 Independent Director
Randall S. Livingston 67 2009 Independent Director
David Botstein 78 2012 Independent Director
Kathy P. Ordonez 70 2014 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

PACB Comments

Write your thoughts about Pacific Biosciences of California
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ole Rii
Ole Rii Jun 27, 2022 7:53AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Push it back to 6 USD so I can leavy with no looses
Reply
0 0
Report
Batuhan Babür
Batuhan Babür Jun 17, 2022 1:18PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Brutal
Reply
0 0
Report
Ole Rii
Ole Rii Mar 29, 2022 7:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
25 USD by the end of the year
Reply
0 0
Report
Crim Jamer
Crim Jamer Mar 29, 2022 7:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I need 44 for breakeven
Reply
0 0
Report
Crim Jamer
Crim Jamer Mar 29, 2022 7:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
wich year?
Reply
0 0
Report
gtf udude
gtf udude Mar 22, 2022 11:08AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
10$ is undervalued imho. Great entry price.
Reply
1 0
Report
Ken Burian
Ken Burian Mar 22, 2022 11:08AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
if $10 is undervalued, then how is $8.34?
Reply
0 0
Report
Crim Jamer
Crim Jamer Mar 22, 2022 11:08AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I taught 44 was undervalued
Reply
0 0
Report
Crim Jamer
Crim Jamer Mar 22, 2022 11:08AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ken Burian and 4?
Reply
0 0
Report
Andrius Naprušis
Andrius Naprušis Feb 05, 2022 5:53AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
why feb earnings is not released?
Reply
0 0
Report
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Feb 02, 2022 8:06PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Addet at 11,20 long
Reply
2 0
Report
Crim Jamer
Crim Jamer Jan 10, 2022 4:25PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
10 months ago Morgan Stanley raised price target to 45. This was the sell signale.
Reply
3 0
Report
Crim Jamer
Crim Jamer Jan 10, 2022 4:25PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
120.000 new shares for employees(80k+40k rsu). The 80k will be sold on monday instantly.
Reply
0 0
Report
Crim Jamer
Crim Jamer Nov 02, 2021 4:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It's a growth stock with ascensing revenues. Nothing else matters
Reply
1 0
Report
Crim Jamer
Crim Jamer Nov 02, 2021 4:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
NASDAQ:PACB): Q3 Non-GAAP EPS of -$0.23 beats by $0.01; GAAP EPS of $0.08 beats by $0.30.Revenue of $34.89M
Reply
2 0
Report
Crim Jamer
Crim Jamer Nov 02, 2021 4:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
not so fantastic, maybe encourages the shorters tomorrow. Alltough technically it's bullish and the whole smallcap sector gains this week. We'll see.
Reply
0 0
Report
Greg Wootton
Greg Wootton May 15, 2021 6:50PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ark Invest just bought a lot 250000 shares this week .go Cathy
Reply
6 0
Report
andrew mccorkle
andrew mccorkle May 15, 2021 6:50PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
88i
Reply
0 0
Report
Crim Jamer
Crim Jamer May 15, 2021 6:50PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
it's a bad sign!
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email